Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

LiverTrace is designed for adults considered at risk for liver cancer, including those with previous liver conditions.

Foundation funds five new research projects, bringing 2025 total to $5.2 millionNEW YORK, Jan. 6, 2026 /PRNewswire/ -- The ...

A new AI tool BMVision speeds up kidney cancer detection, cutting radiology review time by a third and supporting earlier, ...

Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.

Expanding U.S. market access with an experienced technology investor and AI-driven growth strategistVancouver, British Columbia--(Newsfile Corp. - December 30, 2025) - BioMark Diagnostics Inc. (CSE: ...

Deep learning model analyzes mammograms to predict breast cancer risk up to five years in advance, now being tested at ...

VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035([1]) , driven by a fundamental shift in cancer ...

A blood-based liquid biopsy test detects early-onset colorectal cancer with strong diagnostic performance and high ...